It was reported that after a surgery on a patient's left on (b)(6) 2021, the patient developed endophthalmitis two days later, on (b)(6) 2021.
During the surgery, several medications had been used, including the endosol.
At the time of reporting the patient was being treated with antibiotics at a separate hospital from where the operation was performed.
There were no complications noted during the procedure or the following day during his post op follow-up telephone call.
The patient stated that his vision had improved during this call.
No further information was reported.
|
(b)(6).
Product is not returning for evaluation.
Therefore, a failure analysis of the product cannot be completed.
A review of the device history record, labeling, complaint trending, and risk documentation for this device will be performed.
Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.
Attempts have been made to obtain missing information.
However, to date, no response has been received.
All pertinent information available to johnson and johnson surgical vision, inc.
Has been submitted.
|